Brought to you by:

Lockton to ride for cancer research

Facebook Twitter LinkedIn Google

A 13-strong team at Lockton Companies Australia will ride 200km this weekend through WA’s scenic foothills to the Mandurah foreshore to raise funds for cancer research.

Lockton is participating in the MACA Cancer 200 Ride for Research, continuing its support for the Harry Perkins Institute of Medical Research.

Team Lockton for MACA – which has already raised more than $40,000 – will be among 150 corporate and community teams embarking on the two-day bike ride on Saturday. Riders will make their way back on Sunday along the metropolitan coastal plain.

The funds raised will support a brain cancer project focused on turning off genes designed to repair cancer cells, and research into new modes of cancer drug delivery to treat cancer cells more quickly.

“It’s my hope that the funds we raise can save lives and create better outcomes for people living with cancer. Time is a gift and it’s something I hope we can give to more families,” National Manager Corporate Risks & Mining Gerry Favory, who completed his first ride in 2014 and is team captain, said.

Mr Favory’s team includes COO Andrew Wait, WA State Executive Nick Turley, National Manager Corporate Risks Peter Barron, Corporate Risks Manager Ross Corvaia, Life, Accident and Health Consultant Mark Kelt and Client Service Officer Tom Wheeler.

The ride, in its tenth year, is Australia’s biggest fundraising bike ride and has raised more than $40 million for cancer research in WA.

Make a donation to Team Lockton for MACA here.